| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of FAF1 mRNA | affects expression | 16917068
|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene results in decreased expression of FAF1 mRNA | decreases expression | 16917068
|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of FAF1 mRNA | affects expression | 21346803
|
| D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of FAF1 protein | affects expression | 20106945
|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of FAF1 mRNA | affects expression | 16483693
|
| D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of FAF1 mRNA | affects expression | 17331233
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of FAF1 mRNA | decreases expression | 20106945 20064835
|
| D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FAF1 mRNA | decreases expression | 20382639
|
| D016572 |
Cyclosporine |
Cyclosporine results in increased expression of FAF1 mRNA | increases expression | 20106945
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of FAF1 mRNA | increases expression | 17942748
|
| D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FAF1 mRNA | affects cotreatment|increases expression | 17942748
|
| D017313 |
Fenretinide |
Fenretinide results in decreased expression of FAF1 mRNA | decreases expression | 16570282
|
| C116926 |
rofecoxib |
rofecoxib affects the expression of FAF1 mRNA | affects expression | 17070997
|
| D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of FAF1 mRNA | increases expression | 18175754
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FAF1 mRNA | affects cotreatment|increases expression | 17942748
|
| D014028 |
Tobacco Smoke Pollution |
Tobacco Smoke Pollution results in increased expression of FAF1 mRNA | increases expression | 16137721
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.96 | 14514962 15322242 11752688 |
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.68 | 18287403 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.08 | 17505938 |
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
7.25 | 20464547 20127859 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
7.25 | 14692618 |
| MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
7.25 | 10697514 |
| MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Tobacco Smoke Pollution |
5.66 | 15814487 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.70 | 6695378 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.49 | 16835633 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.02 | 11748828 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.18 | 19183758 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.57 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.83 | 15885639 |
| MESH:D001169 |
Arthritis, Experimental |
|
rofecoxib |
7.83 | 16690336 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Tobacco Smoke Pollution |
3.20 | 19898480 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.12 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.81 | 15746008 |
| MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
4.43 | 16187019 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.92 | 20146248 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
1.92 | 16601279 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.92 | 20435547 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.86 | 16835633 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.79 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.79 | 12907637 21507988 12619106 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
4.79 | 16270382 17159502 |
| MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Tobacco Smoke Pollution |
3.45 | 11212258 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.87 | 20419170 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
7.87 | 16274795 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tobacco Smoke Pollution |
7.87 | 11212258 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 16120746 18670907 18850075 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.74 | 20889678 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.74 | 12371664 |
| MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
5.59 | 16154183 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.98 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.98 | 16105132 17333356 17110522 15861022 16919318 11677210 17681005 |
| MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.86 | 15894690 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.13 | 8697196 15340226 15668235 12621046 16354765 |
| MESH:D003110 |
Colonic Neoplasms |
|
rofecoxib |
3.31 | 12902858 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
2.68 | 17273769 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 17141729 14669216 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 20055451 10048152 15322242 |
| MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.12 | 18551238 |
| MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.85 | 16285004 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.68 | 17107852 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.34 | 18551238 21346803 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
6.34 | 15131321 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.34 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.82 | 11462148 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.46 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.04 | 16714409 18230668 15322242 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.28 | 12538720 |
| MESH:D004715 |
Endometriosis |
|
rofecoxib |
9.59 | 15652904 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.59 | 10568697 9294722 |
| MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.41 | 20426865 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.41 | 16530937 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.85 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
7.85 | 15345470 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.83 | 12168785 12639820 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.83 | 20067830 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.34 | 8708960 |
| MESH:D005909 |
Glioblastoma |
|
Fenretinide |
3.94 | 16187019 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.58 | 20471113 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.58 | 10048152 11294989 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.54 | 15720958 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.00 | 15340226 12621046 16120746 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 16354765 18606429 15340226 8697196 16959395 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.04 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.04 | 18670907 18850075 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.91 | 16945680 16569931 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.55 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.54 | 17937319 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.38 | 12200463 12878042 |
| MESH:D007249 |
Inflammation |
|
Tobacco Smoke Pollution |
5.38 | 18590791 |
| MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.33 | 14714311 |
| MESH:D007410 |
Intestinal Diseases |
|
rofecoxib |
5.14 | 15831440 |
| MESH:D007417 |
Intestinal Polyps |
|
rofecoxib |
5.46 | 11245490 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 16580747 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.58 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.38 | 8314463 10903974 18776723 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
7.50 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.50 | 12371664 |
| MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
6.18 | 16707609 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rofecoxib |
2.79 | 17565644 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.79 | 12878042 |
| MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
7.55 | 15890375 18177683 9163691 2125692 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.55 | 21137059 20195826 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.55 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
5.97 | 8603461 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.97 | 12151625 |
| MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
4.13 | 17365036 |
| MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
4.94 | 14755239 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.94 | 18816296 20869020 18569708 20135361 20464547 18520028 6695378 20064080 17053015 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.94 | 11884234 19555203 |
| MESH:D008175 |
Lung Neoplasms |
|
Tobacco Smoke Pollution |
4.94 | 16288123 12111688 11091918 3440675 |
| MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.15 | 14737004 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
3.62 | 10697514 |
| MESH:D008545 |
Melanoma |
|
Fenretinide |
2.84 | 16270382 |
| MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.21 | 16966607 16166281 18303189 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.92 | 16801185 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
14.93 | 16381670 |
| MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
14.93 | 16274795 |
| MESH:D009062 |
Mouth Neoplasms |
|
Tobacco Smoke Pollution |
14.93 | 15006635 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.08 | 12213967 |
| MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.97 | 18551238 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.44 | 11141357 |
| MESH:D009369 |
Neoplasms |
|
Fenretinide |
5.44 | 15958647 17353921 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.58 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.36 | 19348381 18481113 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.31 | 14600291 |
| MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.80 | 16303764 |
| MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.50 | 16049721 12819281 |
| MESH:D010003 |
Osteoarthritis |
|
rofecoxib |
4.42 | 16690336 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
3.25 | 16133793 |
| MESH:D010149 |
Pain, Postoperative |
|
rofecoxib |
5.52 | 16678543 18165598 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
3.37 | 15580305 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.77 | 11578682 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
| MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
5.00 | 10923243 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.29 | 12371664 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.31 | 11118676 11399792 11222880 11896295 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.66 | 17292933 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
2.66 | 17024972 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.66 | 18760546 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.43 | 15861022 16919318 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.25 | 16882103 |
| MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.06 | 17365031 17975199 17322281 15814490 |
| MESH:D012135 |
Respiratory Sounds |
|
Tobacco Smoke Pollution |
4.73 | 18410779 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
| MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
4.46 | 16303925 |
| MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.58 | 18551238 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
13.93 | 19755658 10029692 |
| MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
13.93 | 16467112 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.93 | 16192470 |
| MESH:D012878 |
Skin Neoplasms |
|
Tobacco Smoke Pollution |
13.93 | 18590791 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.08 | 16709447 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.71 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.22 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
12.26 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
12.26 | 17053015 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
12.26 | 16720286 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tobacco Smoke Pollution |
12.26 | 12846360 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.43 | 10091137 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
4.64 | 16154183 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.39 | 14692618 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.12 | 1336536 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.62 | 14671159 15869587 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.58 | 17120751 |